Delivering Exceptional Outcome™
Applied Biologics™ is a global leader in advancing regenerative medicine, developing and supporting research using amnion-derived technology and patient advocacy. Amniotic membrane and fluid offer a rich source of native organic cellular components that deserve extensive research to explore their full potential. Immune privilege is a unique characteristic that differentiates this human allograft from other tissue sources. Applied Biologics™ is focused on optimizing the regenerative potential of this unique allograft. Since 2010, Applied Biologics™ has been an industry leader in providing innovative amnion-technology for management of soft-tissue defects, orthopedic procedures, chronic wounds, and nerve, ligament and tendon repair.
AmnioGenic Therapy® – Developed and delivered exclusively by Applied Biologics™
- Live Donors: Those allografts derived from live donors are processed and packaged at a U.S. Food and Drug Administration (FDA) registered and American Association of Tissue Banks (AATB) accredited tissue bank (available upon request), in accordance with cGTP standards and regulated by the FDA under 21 CFR Part 1271 and Section 361 of the Public Health Service Act.
Amnion & Base Tissue
AmnioGenic Therapy®, delivered exclusively by Applied Biologics™, addresses a broad spectrum of clinical applications and specialties:
- Soft-Tissue Defects
- Localized Inflammation
- Tendon, Ligament, Nerve Repair
- Fibroblast Reduction
- Sports Injury & Orthopedics
- General Surgery & Trauma
- Chronic Wound Management
- Urology & OB/GYN
The Applied Biologics™ executive team and our professional sales force consists mainly of former military and medically trained professionals. All of our sales representatives are professional, responsive and knowledgeable. Our client’s products are represented accurately and faithfully to our customer base of hospitals, doctors and caregivers.